Cerivastatin.
Cheng-Lai A.
Heart Dis. 2000 Jan-Feb;2(1):93-9.
[New antilipemics: prospects].
Farnier M.
Therapie. 2003 Jan-Feb;58(1):97-105. doi: 10.2515/therapie:2003014.
Trends in epidemiology of dyslipidemias in India.
Sharma S, Gaur K, Gupta R.
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S20-S28. doi: 10.1016/j.ihj.2023.11.266. Epub 2024 Feb 12.
Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy.
Sanchez VA, Dinh PC Jr, Monahan PO, Althouse S, Rooker J, Sesso HD, Dolan ME, Weinzerl M, Feldman DR, Fung C, Einhorn LH, Frisina RD, Travis LB.
JAMA Oncol. 2024 Jul 1;10(7):912-922. doi: 10.1001/jamaoncol.2024.1233.
Diagnosing and managing vascular dementia.
Igoumenou A, Ebmeier KP.
Practitioner. 2012 Jan;256(1747):13-6, 2.
The causal relationship between pure hypercholesterolemia and psoriasis: A bidirectional, two-sample Mendelian randomization study.
Bai R, Ren L, Guo J, Xian N, Luo R, Chang Y, Dai Y, Lei H, Zheng Y.
Skin Res Technol. 2023 Dec;29(12):e13533. doi: 10.1111/srt.13533.
Inclisiran in Chronic Kidney Disease Patients: A Real-World Experience.
Dello Strologo A, Franculli A, Saporito P, Miani N, Bellasi A, Lido P, Di Lullo L, Ronco C, Peverini P.
Cardiorenal Med. 2026;16(1):87-94. doi: 10.1159/000549898. Epub 2026 Feb 4.
Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?
Brunham LR.
Curr Opin Lipidol. 2024 Aug 1;35(4):219-221. doi: 10.1097/MOL.0000000000000938. Epub 2024 Apr 19.
Flavonoids and metabolic syndrome.
Galleano M, Calabro V, Prince PD, Litterio MC, Piotrkowski B, Vazquez-Prieto MA, Miatello RM, Oteiza PI, Fraga CG.
Ann N Y Acad Sci. 2012 Jul;1259:87-94. doi: 10.1111/j.1749-6632.2012.06511.x.
Lipid Metabolism, Methylation Aberrant, and Osteoporosis: A Multi-omics Study Based on Mendelian Randomization.
Zhang Z, Duan Y, Huo J.
Calcif Tissue Int. 2024 Feb;114(2):147-156. doi: 10.1007/s00223-023-01160-6. Epub 2023 Dec 10.
